Press Releases September 3, 2026 06:00 AM

Ducommun to Participate in Gabelli Aerospace & Defense Symposium

Ducommun's CEO to Present at 32nd Annual Gabelli Aerospace & Defense Symposium

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
DCO

Ducommun Incorporated announced that its chairman, president, and CEO Stephen G. Oswald will participate in the 32nd Annual Gabelli Aerospace & Defense Symposium on September 10, 2026. The event will include a general presentation and investor meetings, highlighting Ducommun's business in aerospace, defense, and space markets.

Ducommun to Participate in Gabelli Aerospace & Defense Symposium
DCO
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Ducommun's CEO will present at a major industry symposium, indicating active investor engagement.
  • The company specializes in electronic and structural systems for aerospace, defense, and space sectors.
  • Preparation for potential strategic updates or business insights presentation to investors.

COSTA MESA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) announced today that Stephen G. Oswald, the Company’s chairman, president and chief executive officer, will participate in the upcoming 32nd Annual Gabelli Aerospace & Defense Symposium on September 10, 2026. A general presentation will be held at 11:30 a.m. Eastern, with one-on-one investor meetings scheduled throughout the day.

Additional information will be posted on the Company’s website at www.ducommun.com when available, including a copy of any presentation material. The presentation will be available live online and can be accessed by registering using this link. Institutional investors are welcome to contact Gabelli to arrange one-on-one calls with management.

About Ducommun Incorporated
Ducommun Incorporated delivers value-added innovative products, aftermarket and manufacturing solutions to customers in the aerospace, defense and space markets and aspires to contribute to the advancement of those industries. Founded in 1849, the Company specializes in two core areas — Electronic Systems and Structural Systems — to produce complex products and components for commercial aircraft platforms and mission-critical military and space programs. For more information, visit Ducommun.com.

Contacts
Suman Mookerji, Senior Vice President and Chief Financial Officer
657.335.3665, SMookerji@ducommun.com


Risks

  • Market conditions in aerospace and defense can be volatile and influenced by government spending.
  • Dependence on commercial aircraft and military program cycles may impact revenue stability.
  • Potential geopolitical uncertainties affecting defense and aerospace sectors.

More from Press Releases

Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 Sep 3, 2026 Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference Sep 3, 2026 Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026 Sep 3, 2026 C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting Sep 3, 2026 LeonaBio to Participate in Cantor Global Healthcare Conference 2026 Sep 3, 2026